Want to see ZLAB full AI Analyst Report?
ETFs with Zai Lab (ZLAB) Exposure
The following ETFs maintain exposure to Zai Lab (ZLAB). ETF holdings data are updated periodically, based on the latest holdings the ETFs report, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
16 ETFs Hold Zai Lab (ZLAB)
| Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in ZLAB |
|---|---|---|---|---|---|---|
| CHB | ― | ― | ― | 3.96% | $55.94K | <0.01% |
| BBP | Virtus LifeSci Biotech Products ETF | $136.83M | 0.34% | 1.67% | $2.27M | 0.08% |
| SBIO | ALPS Medical Breakthroughs ETF | $187.80M | 0.50% | 1.65% | $3.04M | 0.11% |
| CANC | Tema Oncology ETF | $216.18M | 0.75% | 1.62% | $3.51M | 0.13% |
| PGJ | Invesco Golden Dragon China ETF | $76.42M | 0.70% | 0.77% | $591.48K | 0.02% |
| FNI | ― | ― | ― | 0.70% | $520.01K | 0.01% |
| FMED | Fidelity Disruptive Medicine ETF | $54.39M | 0.50% | 0.63% | $341.50K | 0.01% |
| NSI | National Security Emerging Markets Index ETF | $40.92M | 0.75% | 0.18% | $73.29K | <0.01% |
| IBB | iShares Biotechnology ETF | $11.52B | 0.44% | 0.14% | $16.36M | 0.59% |
| BCEM | Baron Emerging Markets Select ETF | $48.63M | 0.80% | 0.13% | $61.02K | <0.01% |
| OM3E | iShares NASDAQ US Biotechnology UCITS ETF | $78.53M | 0.37% | 0.06% | $847.58K | 0.03% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | $120.43M | 0.19% | 0.06% | $75.13K | <0.01% |
| 0B4A | ― | ― | ― | 0.04% | $443.99K | 0.01% |
| EMCR | Xtrackers Emerging Markets Carbon Reduction and Climate Improvers ETF | $56.77M | 0.15% | <0.01% | $3,509.13 | <0.01% |
| ONEQ | Fidelity Nasdaq Composite Index ETF | $10.76B | 0.21% | <0.01% | $569.78K | 0.02% |
| SPGM | SPDR Portfolio MSCI Global Stock Market ETF | $1.82B | 0.09% | <0.01% | $92.86K | <0.01% |
| Symbol | % Weight in ETF | ETF Name | AUM | Expense Ratio | Market Value | % Weight in ZLAB |
|---|---|---|---|---|---|---|
| CHB | 3.96% | ― | ― | ― | $55.94K | <0.01% |
| BBP | 1.67% | Virtus LifeSci Biotech Products ETF | $136.83M | 0.34% | $2.27M | 0.08% |
| SBIO | 1.65% | ALPS Medical Breakthroughs ETF | $187.80M | 0.50% | $3.04M | 0.11% |
| CANC | 1.62% | Tema Oncology ETF | $216.18M | 0.75% | $3.51M | 0.13% |
| PGJ | 0.77% | Invesco Golden Dragon China ETF | $76.42M | 0.70% | $591.48K | 0.02% |
| FNI | 0.70% | ― | ― | ― | $520.01K | 0.01% |
| FMED | 0.63% | Fidelity Disruptive Medicine ETF | $54.39M | 0.50% | $341.50K | 0.01% |
| NSI | 0.18% | National Security Emerging Markets Index ETF | $40.92M | 0.75% | $73.29K | <0.01% |
| IBB | 0.14% | iShares Biotechnology ETF | $11.52B | 0.44% | $16.36M | 0.59% |
| BCEM | 0.13% | Baron Emerging Markets Select ETF | $48.63M | 0.80% | $61.02K | <0.01% |
| OM3E | 0.06% | iShares NASDAQ US Biotechnology UCITS ETF | $78.53M | 0.37% | $847.58K | 0.03% |
| IBBQ | 0.06% | Invesco Nasdaq Biotechnology ETF | $120.43M | 0.19% | $75.13K | <0.01% |
| 0B4A | 0.04% | ― | ― | ― | $443.99K | 0.01% |
| EMCR | <0.01% | Xtrackers Emerging Markets Carbon Reduction and Climate Improvers ETF | $56.77M | 0.15% | $3,509.13 | <0.01% |
| ONEQ | <0.01% | Fidelity Nasdaq Composite Index ETF | $10.76B | 0.21% | $569.78K | 0.02% |
| SPGM | <0.01% | SPDR Portfolio MSCI Global Stock Market ETF | $1.82B | 0.09% | $92.86K | <0.01% |
Popular ETF Comparisons
ZLAB ETF Exposure FAQ
What ETFs hold Zai Lab stock?
Zai Lab (ZLAB) is currently held by 16 ETFs in TipRanks’ ETF exposure database. The ETF(s) with exposure to ZLAB include iShares (IBB), Tema (CANC) and ALPS (SBIO).
Which ETF has the largest exposure to ZLAB?
The ETF with the largest exposure to ZLAB is iShares (IBB), with approximately $16.36M in market value exposure.
How much ZLAB stock is held by ETFs?
ETFs currently hold approximately $26.82M worth of Zai Lab (ZLAB) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.